The use of the fecal occult blood test (FOBT) for colorectal cancer (CRC) screening is
supported by randomized trials demonstrating effectiveness in cancer prevention and widely …

Colorectal cancer (CRC) is a very heterogeneous disease that is caused by the interaction
of genetic and environmental factors. CRC develops through a gradual accumulation of …

Screening, followed by colonoscopic polypectomy (or surgery for malignant lesions),
prevents incident colorectal cancer and mortality. However, there are variations in effective …

Although colorectal cancer (CRC) is a common cause of cancer-related death, it is
fortunately amenable to screening with faecal tests for occult blood and endoscopic tests …

There is a wide choice of fecal occult blood tests (FOBTs) for colorectal cancer screening.
Goal: To highlight the issues applicable when choosing a FOBT, in particular which FOBT is …

The first evidence that screening for colorectal cancer (CRC) could effectively reduce
mortality dates back 20 years. However, actual population screening has, in many countries …

Colorectal cancer is a major public health challenge worldwide. In Europe it is the first
malignancy in terms of incidence and the second in terms of mortality in both genders …

Fecal immunochemical tests for hemoglobin (FIT) are changing the manner in which
colorectal cancer (CRC) is screened. Although these tests are being performed worldwide …

Screening has a central role in colorectal cancer (CRC) control. Different screening tests are
effective in reducing CRC-specific mortality. Influence on cancer incidence depends on test …

Colorectal cancer (CRC) is an ideal target for early detection and prevention through
screening. Noninvasive screening options are the guaiac fecal occult blood test and the …